IP Library › Granted Patent US 11,383,988
Granted Patent B2
US 11,383,988 · App. 16/858,548 · Granted Jul 12, 2022

Oolitic aragonite beads and methods therefor

Inventors: Anthony Myers (Gadsden, AL); Alyson Myers (Gadsden, AL); Harold Meherg (Culver City, CA); Patrick Soon-Shiong (Culver City, CA)
Assignees: Nant Holdings IP, LLP; Calcean Minerals and Materials, LLC
C01F11/185A61K8/042A61K8/19A61K8/733C09C1/024A61K8/44A61K8/64A61K2800/10A61K2800/412A61K2800/621C01P2004/51C01P2004/61
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,383,988
App. No.
16/858,548
Granted
Jul 12, 2022
Kind
B2
Abstract

Disclosed herein are personal care and/or cosmetic compositions, comprising a carrier and oolitic aragonite beads having an average diameter between 10 nm to 10 mm. Also disclosed herein are methods of reducing plastic contamination and/or pollution comprising making a cosmetic or personal care composition, wherein at least a portion to all (100%) of the plastic microbeads in the cosmetic or personal care composition are replaced with oolitic aragonite. Also disclosed herein are a milling system and milling methods for producing oolitic aragonite particles having a clean top size in which the particles are screened to remove any oversized particles. Additional uses include drug-loaded aragonite particles for therapeutic drug delivery and chromatography media.

Claims (10)

1. A composition comprising oolitic aragonite particles, wherein the oolitic aragonite particles have an average particle size of between 100 nm to 1 mm, and a median (D50) particle size distribution (PSD) of between 2.0 to 3.5 μm, and a Hunter brightness level of about 94.

2. The composition of claim 1 , wherein the oolitic aragonite particles have a D50 PSD of between 2.5 to 3.5 μm.

3. The composition of claim 1 , wherein the oolitic aragonite particles are loaded with a molecule.

4. The composition of claim 1 , wherein the oolitic aragonite particles are surface treated.

5. The composition of claim 3 , wherein the molecule is a chemotherapeutic.

6. The composition of claim 3 , wherein the molecule is a protein and the oolitic aragonite particles are functionalized to bind the protein.

7. The composition of claim 1 , wherein the oolitic aragonite particles are formulated as chromatography media.

8. The composition of claim 1 , wherein the oolitic aragonite particles are formulated as a synthesized pearl composition.

9. The composition of claim 1 , wherein the oolitic aragonite particles are milled.

10. The composition of claim 1 , wherein the oolitic aragonite particles are ball milled.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2022
From: MYERS, ANTHONY; MYERS, ALYSON; MEHERG, HAROLD
To: CALCEAN MINERALS AND MATERIALS, LLC
Reel/Frame 059922/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2022
From: SOON-SHIONG, PATRICK
To: NANT HOLDINGS IP, LLC
Reel/Frame 059922/0419 →
Continuity (5)
Provisional Application 62964500 · Jan 22, 2020
Provisional Application 62951899 · Dec 20, 2019
Provisional Application 62902314 · Sep 18, 2019
Provisional Application 62839322 · Apr 26, 2019
Related Publication 20200308015A1 · Oct 1, 2020
Cited By (3)
US 12,419,813 US 12,565,740 US 12,714,654